advertisement

Topcon

Huang S 24

Showing records 1 to 24 | Display all abstracts from Huang S

91988 Long-term effect of YAG laser iridotomy on corneal endothelium in primary angle closure suspects: a 72-month randomised controlled study
Liao C
British Journal of Ophthalmology 2021; 105: 348-353
92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Yu H
FASEB Journal 2021; 35: e21405
92418 Changing trends in glaucoma surgery within Australia
Sun MT
British Journal of Ophthalmology 2022; 106: 957-961
91988 Long-term effect of YAG laser iridotomy on corneal endothelium in primary angle closure suspects: a 72-month randomised controlled study
Zhang J
British Journal of Ophthalmology 2021; 105: 348-353
92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Zhong H
FASEB Journal 2021; 35: e21405
92418 Changing trends in glaucoma surgery within Australia
Madike R
British Journal of Ophthalmology 2022; 106: 957-961
91988 Long-term effect of YAG laser iridotomy on corneal endothelium in primary angle closure suspects: a 72-month randomised controlled study
Jiang Y
British Journal of Ophthalmology 2021; 105: 348-353
92418 Changing trends in glaucoma surgery within Australia
Huang S
British Journal of Ophthalmology 2022; 106: 957-961
92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Li N
FASEB Journal 2021; 35: e21405
91988 Long-term effect of YAG laser iridotomy on corneal endothelium in primary angle closure suspects: a 72-month randomised controlled study
Huang S
British Journal of Ophthalmology 2021; 105: 348-353
92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Chen K
FASEB Journal 2021; 35: e21405
92418 Changing trends in glaucoma surgery within Australia
Cameron C
British Journal of Ophthalmology 2022; 106: 957-961
92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Chen J
FASEB Journal 2021; 35: e21405
91988 Long-term effect of YAG laser iridotomy on corneal endothelium in primary angle closure suspects: a 72-month randomised controlled study
Aung T
British Journal of Ophthalmology 2021; 105: 348-353
92418 Changing trends in glaucoma surgery within Australia
Selva D
British Journal of Ophthalmology 2022; 106: 957-961
91988 Long-term effect of YAG laser iridotomy on corneal endothelium in primary angle closure suspects: a 72-month randomised controlled study
Foster PJ
British Journal of Ophthalmology 2021; 105: 348-353
92418 Changing trends in glaucoma surgery within Australia
Casson RJ
British Journal of Ophthalmology 2022; 106: 957-961
92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Sun J
FASEB Journal 2021; 35: e21405
91988 Long-term effect of YAG laser iridotomy on corneal endothelium in primary angle closure suspects: a 72-month randomised controlled study
Friedman D
British Journal of Ophthalmology 2021; 105: 348-353
92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Xu L
FASEB Journal 2021; 35: e21405
92418 Changing trends in glaucoma surgery within Australia
Wong CX
British Journal of Ophthalmology 2022; 106: 957-961
92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Wang J
FASEB Journal 2021; 35: e21405
91988 Long-term effect of YAG laser iridotomy on corneal endothelium in primary angle closure suspects: a 72-month randomised controlled study
He M
British Journal of Ophthalmology 2021; 105: 348-353
92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Zhang M; Liu X; Deng L; Huang P; Huang S; Shen X; Zhong Y
FASEB Journal 2021; 35: e21405

Issue 22-1

Change Issue


advertisement

Oculus